学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CHEMOTHERAPEUTIC APPROACHES TO THE TREATMENT OF THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS)
被引:294
作者
:
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
机构
:
来源
:
JOURNAL OF MEDICINAL CHEMISTRY
|
1986年
/ 29卷
/ 09期
关键词
:
D O I
:
10.1021/jm00159a001
中图分类号
:
R914 [药物化学];
学科分类号
:
100701 ;
摘要
:
引用
收藏
页码:1561 / 1569
页数:9
相关论文
共 103 条
[1]
MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III
[J].
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ALLAN, JS
;
COLIGAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
COLIGAN, JE
;
BARIN, F
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
BARIN, F
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
MCLANE, MF
;
SODROSKI, JG
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
SODROSKI, JG
;
ROSEN, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ROSEN, CA
;
HASELTINE, WA
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
HASELTINE, WA
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
LEE, TH
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ESSEX, M
.
SCIENCE,
1985,
228
(4703)
:1091
-1094
[2]
A NEW HTLV-III LAV ENCODED ANTIGEN DETECTED BY ANTIBODIES FROM AIDS PATIENTS
[J].
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ALLAN, JS
;
COLIGAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
COLIGAN, JE
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
LEE, TH
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
MCLANE, MF
;
KANKI, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
KANKI, PJ
;
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
GROOPMAN, JE
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ESSEX, M
.
SCIENCE,
1985,
230
(4727)
:810
-813
[3]
ANAND R, 1986, LANCET, V1, P97
[4]
TREATMENT OF INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
[J].
ARMSTRONG, D
论文数:
0
引用数:
0
h-index:
0
ARMSTRONG, D
;
GOLD, JWM
论文数:
0
引用数:
0
h-index:
0
GOLD, JWM
;
DRYJANSKI, J
论文数:
0
引用数:
0
h-index:
0
DRYJANSKI, J
;
WHIMBEY, E
论文数:
0
引用数:
0
h-index:
0
WHIMBEY, E
;
POLSKY, B
论文数:
0
引用数:
0
h-index:
0
POLSKY, B
;
HAWKINS, C
论文数:
0
引用数:
0
h-index:
0
HAWKINS, C
;
BROWN, AE
论文数:
0
引用数:
0
h-index:
0
BROWN, AE
;
BERNARD, E
论文数:
0
引用数:
0
h-index:
0
BERNARD, E
;
KIEHN, TE
论文数:
0
引用数:
0
h-index:
0
KIEHN, TE
.
ANNALS OF INTERNAL MEDICINE,
1985,
103
(05)
:738
-743
[5]
TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III)
[J].
ARYA, SK
论文数:
0
引用数:
0
h-index:
0
ARYA, SK
;
GUO, C
论文数:
0
引用数:
0
h-index:
0
GUO, C
;
JOSEPHS, SF
论文数:
0
引用数:
0
h-index:
0
JOSEPHS, SF
;
WONGSTAAL, F
论文数:
0
引用数:
0
h-index:
0
WONGSTAAL, F
.
SCIENCE,
1985,
229
(4708)
:69
-73
[6]
AURINTRICARBOXYLIC ACID AND EVANS BLUE REPRESENT 2 DIFFERENT CLASSES OF ANIONIC COMPOUNDS WHICH SELECTIVELY INHIBIT THE CYTOPATHOGENICITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS
[J].
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
BALZARINI, J
;
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
MITSUYA, H
;
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
DECLERCQ, E
;
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
BRODER, S
.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
136
(01)
:64
-71
[7]
COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
[J].
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BALZARINI, J
;
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
MITSUYA, H
;
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
DECLERCQ, E
;
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BRODER, S
.
INTERNATIONAL JOURNAL OF CANCER,
1986,
37
(03)
:451
-457
[8]
VIRUS ENVELOPE PROTEIN OF HTLV-III REPRESENTS MAJOR TARGET ANTIGEN FOR ANTIBODIES IN AIDS PATIENTS
[J].
BARIN, F
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
BARIN, F
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
MCLANE, MF
;
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
ALLAN, JS
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
LEE, TH
;
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
GROOPMAN, JE
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
ESSEX, M
.
SCIENCE,
1985,
228
(4703)
:1094
-1096
[9]
ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
[J].
BARRESINOUSSI, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
BARRESINOUSSI, F
;
CHERMANN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHERMANN, JC
;
REY, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
REY, F
;
NUGEYRE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
NUGEYRE, MT
;
CHAMARET, S
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHAMARET, S
;
GRUEST, J
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
GRUEST, J
;
DAUGUET, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
DAUGUET, C
;
AXLERBLIN, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
AXLERBLIN, C
;
VEZINETBRUN, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
VEZINETBRUN, F
;
ROUZIOUX, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROUZIOUX, C
;
ROZENBAUM, W
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROZENBAUM, W
;
MONTAGNIER, L
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
MONTAGNIER, L
.
SCIENCE,
1983,
220
(4599)
:868
-871
[10]
BELDEKAS JC, 1985, LANCET, V2, P1128
←
1
2
3
4
5
6
7
8
9
10
→
共 103 条
[1]
MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III
[J].
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ALLAN, JS
;
COLIGAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
COLIGAN, JE
;
BARIN, F
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
BARIN, F
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
MCLANE, MF
;
SODROSKI, JG
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
SODROSKI, JG
;
ROSEN, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ROSEN, CA
;
HASELTINE, WA
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
HASELTINE, WA
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
LEE, TH
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ESSEX, M
.
SCIENCE,
1985,
228
(4703)
:1091
-1094
[2]
A NEW HTLV-III LAV ENCODED ANTIGEN DETECTED BY ANTIBODIES FROM AIDS PATIENTS
[J].
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ALLAN, JS
;
COLIGAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
COLIGAN, JE
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
LEE, TH
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
MCLANE, MF
;
KANKI, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
KANKI, PJ
;
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
GROOPMAN, JE
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NIAID,IMMUNOGENET LAB,BETHESDA,MD 20205
ESSEX, M
.
SCIENCE,
1985,
230
(4727)
:810
-813
[3]
ANAND R, 1986, LANCET, V1, P97
[4]
TREATMENT OF INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
[J].
ARMSTRONG, D
论文数:
0
引用数:
0
h-index:
0
ARMSTRONG, D
;
GOLD, JWM
论文数:
0
引用数:
0
h-index:
0
GOLD, JWM
;
DRYJANSKI, J
论文数:
0
引用数:
0
h-index:
0
DRYJANSKI, J
;
WHIMBEY, E
论文数:
0
引用数:
0
h-index:
0
WHIMBEY, E
;
POLSKY, B
论文数:
0
引用数:
0
h-index:
0
POLSKY, B
;
HAWKINS, C
论文数:
0
引用数:
0
h-index:
0
HAWKINS, C
;
BROWN, AE
论文数:
0
引用数:
0
h-index:
0
BROWN, AE
;
BERNARD, E
论文数:
0
引用数:
0
h-index:
0
BERNARD, E
;
KIEHN, TE
论文数:
0
引用数:
0
h-index:
0
KIEHN, TE
.
ANNALS OF INTERNAL MEDICINE,
1985,
103
(05)
:738
-743
[5]
TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III)
[J].
ARYA, SK
论文数:
0
引用数:
0
h-index:
0
ARYA, SK
;
GUO, C
论文数:
0
引用数:
0
h-index:
0
GUO, C
;
JOSEPHS, SF
论文数:
0
引用数:
0
h-index:
0
JOSEPHS, SF
;
WONGSTAAL, F
论文数:
0
引用数:
0
h-index:
0
WONGSTAAL, F
.
SCIENCE,
1985,
229
(4708)
:69
-73
[6]
AURINTRICARBOXYLIC ACID AND EVANS BLUE REPRESENT 2 DIFFERENT CLASSES OF ANIONIC COMPOUNDS WHICH SELECTIVELY INHIBIT THE CYTOPATHOGENICITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS
[J].
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
BALZARINI, J
;
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
MITSUYA, H
;
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
DECLERCQ, E
;
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20205
BRODER, S
.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
136
(01)
:64
-71
[7]
COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
[J].
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BALZARINI, J
;
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
MITSUYA, H
;
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
DECLERCQ, E
;
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BRODER, S
.
INTERNATIONAL JOURNAL OF CANCER,
1986,
37
(03)
:451
-457
[8]
VIRUS ENVELOPE PROTEIN OF HTLV-III REPRESENTS MAJOR TARGET ANTIGEN FOR ANTIBODIES IN AIDS PATIENTS
[J].
BARIN, F
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
BARIN, F
;
MCLANE, MF
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
MCLANE, MF
;
ALLAN, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
ALLAN, JS
;
LEE, TH
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
LEE, TH
;
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
GROOPMAN, JE
;
ESSEX, M
论文数:
0
引用数:
0
h-index:
0
机构:
NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
ESSEX, M
.
SCIENCE,
1985,
228
(4703)
:1094
-1096
[9]
ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
[J].
BARRESINOUSSI, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
BARRESINOUSSI, F
;
CHERMANN, JC
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHERMANN, JC
;
REY, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
REY, F
;
NUGEYRE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
NUGEYRE, MT
;
CHAMARET, S
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
CHAMARET, S
;
GRUEST, J
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
GRUEST, J
;
DAUGUET, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
DAUGUET, C
;
AXLERBLIN, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
AXLERBLIN, C
;
VEZINETBRUN, F
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
VEZINETBRUN, F
;
ROUZIOUX, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROUZIOUX, C
;
ROZENBAUM, W
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
ROZENBAUM, W
;
MONTAGNIER, L
论文数:
0
引用数:
0
h-index:
0
机构:
HOP CLAUDE BERNARD, CENT VIROL LAB, F-75019 PARIS, FRANCE
MONTAGNIER, L
.
SCIENCE,
1983,
220
(4599)
:868
-871
[10]
BELDEKAS JC, 1985, LANCET, V2, P1128
←
1
2
3
4
5
6
7
8
9
10
→